Is my portfolio
One Report to Answer all your Questions!
Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
917.90
3.05 (0.33%) Natco Pharma - Quaterly Results
Date: 15-11-2025
A slight decline in the revenue of Rs. 12643.00 millions was seen for the September 2025 quarter as against Rs. 12926.00 millions during year-ago period.The Company's Net profit for the September 2025 quarter have declined marginally to Rs. 5009.00 millions as against Rs. 6611.00 millions reported during the corresponding quarter ended.Operating Profit reported a sharp decline to 6458.00 millions from 8421.00 millions in the corresponding previous quarter.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202509 | 202409 | % Var | 202509 | 202409 | % Var | 202503 | 202403 | % Var | |
| Sales | 12643.00 | 12926.00 | -2.19 | 24570.00 | 25295.00 | -2.87 | 40945.00 | 35689.00 | 14.73 |
| Other Income | 933.00 | 514.00 | 81.52 | 1529.00 | 912.00 | 67.65 | 3213.00 | 1047.00 | 206.88 |
| PBIDT | 6458.00 | 8421.00 | -23.31 | 12451.00 | 16449.00 | -24.31 | 24656.00 | 17417.00 | 41.56 |
| Interest | 117.00 | 30.00 | 290.00 | 143.00 | 74.00 | 93.24 | 196.00 | 145.00 | 35.17 |
| PBDT | 6341.00 | 8391.00 | -24.43 | 12308.00 | 16375.00 | -24.84 | 24460.00 | 17272.00 | 41.62 |
| Depreciation | 481.00 | 422.00 | 13.98 | 1019.00 | 826.00 | 23.37 | 2200.00 | 1719.00 | 27.98 |
| PBT | 5860.00 | 7969.00 | -26.47 | 11289.00 | 15549.00 | -27.40 | 22260.00 | 15553.00 | 43.12 |
| TAX | 851.00 | 1358.00 | -37.33 | 1639.00 | 2575.00 | -36.35 | 3756.00 | 2487.00 | 51.03 |
| Deferred Tax | -455.00 | -120.00 | 279.17 | -727.00 | -227.00 | 220.26 | -319.00 | -361.00 | -11.63 |
| PAT | 5009.00 | 6611.00 | -24.23 | 9650.00 | 12974.00 | -25.62 | 18504.00 | 13066.00 | 41.62 |
| Equity | 358.00 | 358.00 | 0.00 | 358.00 | 358.00 | 0.00 | 358.00 | 358.00 | 0.00 |
| PBIDTM(%) | 51.08 | 65.15 | -21.59 | 50.68 | 65.03 | -22.07 | 60.22 | 48.80 | 23.39 |